Jeffrey Meisner

Jeff Meisner is the Senior Director of Clinical Development and Inflammatory Bowel Disease Program Lead at Locus Biosciences, a clinical-stage company that develops engineered bacteriophage therapeutics to address infectious and inflammatory diseases. He has over 20 years of experience in microbial molecular biology, physiology, and ecology spanning academic research and biotechnology applications in human and animal health. Prior to joining Locus Biosciences, Jeff helped Kaleido Biosciences build an integrated discovery platform focused on developing synthetic oligosaccharides to systemically modulate the function of the human gut microbiome in inflammatory and metabolic diseases. More recently, he served as the Chief Scientific Officer at Resilient Biotics where he oversaw the discovery and development of next-generation microbial products to prevent complex respiratory diseases in cattle, swine, and poultry. Jeff earned his PhD in molecular microbiology at Emory University and completed post-doctoral training at Harvard Medical School and Emory University School of Medicine where his research was focused on bacterial cell envelope biosynthesis.